PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsYoichi Nagata, Dihua Yu, Francisco J. Esteva et al.|Cancer Cell|2004Cited by 1.9k
The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 associationYoichi Nagata, Mitsuyoshi Nakao, Tadashi Anan et al.|Oncogene|1999Cited by 101